***The Iowa Standard is an independent media voice. We rely on grassroots financial supporters to exist. If you appreciate what we do, please consider a one-time sign of support or becoming a monthly supporter (even just $5/month would go a long way in sustaining us!) We also offer advertising options for advocacy groups, events and businesses! If you’ve ever used the phrase “Fake News Media” — this is YOUR chance to do something about it! You can also support us on PayPal at [email protected] or Venmo at Iowa-Standard-2018 or through the mail at: PO Box 112 Sioux Center, IA 51250 Thank you so much for your support and please invite your friends and family to like us on Facebook, sign up for our email newsletter and visit our website!***

Today, President Trump is taking further action under the Defense Production Act to end America’s overreliance on foreign supply chains.

The Administration has used the Defense Production Act more than 30 times to date, helping to secure critical supplies of ventilators, personal protective equipment, testing supplies, pharmaceutical products, and more during the global Coronavirus pandemic.

Now, the Administration is providing a $765 million loan to Kodak to support the launch of Kodak Pharmaceuticals, which will boost America’s domestic production of much-needed drugs. Once fully operational, Kodak Pharmaceuticals will manufacture up to 25 percent of active pharmaceutical ingredients for certain generic medicines.

“This is not about China or India or any one country,” White House Director of Trade and Manufacturing Policy Peter Navarro says. “It’s about America losing its pharmaceutical supply chains to the sweat shops, pollution havens, and tax havens around the world that cheat America out of its pharmaceutical independence.”

MORE: Kodak Shifts Into Drug Production With Help of U.S. Loan

Author: Press Release